FDA-Approval for Bevacizumab-awwb for Treatment of Advanced Cancers
Bevacizumab-awwb has received US FDA approval for the treatment of several cancers. The introduction of a competitor to bevacizumab could possibly help to reduce cost of treatment and increase the availability of the medication, thus ensuring that more patients experience the benefits of the treatment.
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer